Detection Technology Oy · OMXHEX:DETEC
Detection Technology Oy — Q3 2021 Earnings Presentation
15 slides from Detection Technology Oy's earnings presentation, Oct 27, 2021
Slide 1: Q3 Business Review January–September 2021
January–September 2021 Q3 BUSINESS REVIEW President and CEO Hannu Martola | 27 October 2021
Slide 2: Q3 2021 key figures
Q3 2021 23.2 12.5 3.3 14.1 net sales, €m net sales change-% EBIT excluding NRI, €m EBIT-% excluding NRI (20.6) (-23.4) (2.8) (13.4) 2 27.10.2021 Detection Technology | Business review January–September 2021
Slide 3: Q3 2021: Back to growth in all businesses
Q3 2021 Back to growth in all businesses Medical sales experienced double-digit growth, however some deliveries were postponed due to indirect impacts of the global component shortage Industrial solutions saw record sales and grew double-digit, won new strategic customers and projects Security sales
Slide 4: Net sales by quarter
NET SALES BY QUARTER (EUR 1,000) 30,000 25,000 12.5% 20,000 15,000 (YOY change-%) 10,000 5,000 0 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 2018 2019 2020 2021 4 27.10.2021 Detection Technology | Business review January–September 2021
Slide 5: Operating profit
OPERATING PROFIT (EUR 1,000) 6,000 25% 21.4% 5,000 21.0% 20% 19.4% 19.2% 19.1% 17.5% 4,000 16.7% 15.6% 15% 14.1% 13.4% 3,000 12.3% 12.6% 11.8% 10% 2,000 7.5% 5.9% 5% 1,000 0 0% Q118 Q218 Q318 Q418 Q119 Q219 Q319 Q419 Q120 Q220 Q320 Q420 Q121 Q221 Q321 EBIT excluding NRI (EUR 1,000) EBIT-% excluding
Slide 6: Q3 sales split by business unit
Q3 SALES SPLIT BY BUSINESS UNIT NET SALES €m YOY CHANGE-% 16.4% 32.1% IBU 3.8 21.5 TOTAL NET SALES 23.2 €m MBU 11.9 18.8 51.5% SBU 7.5 0.2 6 27.10.2021 Detection Technology | Business review January–September 2021
Slide 7: Q3 sales split by region
Q3 SALES SPLIT BY REGION 5.0% NET SALES €m YOY CHANGE-% 20.8% TOTAL NET SALES AMERICAS 1.2 -24.6 23.2 €m APAC 17.2 26.0 74.2% EMEA 4.8 -10.9 7 27.10.2021 Detection Technology | Business review January–September 2021
Slide 8: Q1-Q3 net sales and EBIT
Q1-Q3 65.1 5.5 7.6 11.7 net sales, €m net sales change-% EBIT excluding NRI, €m EBIT-% excluding NRI (61.7) (-20.4) (6.5) (10.6) 8 27.10.2021 Detection Technology | Business review January–September 2021
Slide 9: Q1-Q3 sales split by business unit
Q1-Q3 SALES SPLIT BY BUSINESS UNIT NET SALES €m YOY CHANGE-% 14.3% 31.0% IBU 9.3 6.4 TOTAL NET SALES 65.1 €m MBU 35.6 25.7 54.7% SBU 20.2 -18.0 9 27.10.2021 Detection Technology | Business review January–September 2021
Slide 10: Q1-Q3 sales split by region
Q1-Q3 SALES SPLIT BY REGION 8.3% NET SALES €m YOY CHANGE-% 19.1% TOTAL NET SALES AMERICAS 5.4 -22.2 65.1 €m APAC 47.2 15.9 72.6% EMEA 12.4 -10.9 10 27.10.2021 Detection Technology | Business review January–September 2021
Slide 11: Key figures
KEY FIGURES Q3 2021 Q3 2020 Q1-Q3 2021 Q1-Q3 2020 FY 2020 Net sales, EUR 1,000 23,210 20,628 65,066 61,653 81,561 Change in net sales, % 12.5% -23.4% 5.5% -20.4% -20.4% Operating profit excluding NRI, EUR 1,000 3,282 2,758 7,618 6,528 8,877 Operating margin excluding NRI, % 14.1% 13.4% 11.7% 10.6% 1
Slide 12: Strategy and events
STRATEGY AND EVENTS Started sales of Aurora XS Invested in speeding up the product development cycle Implemented added value production processes on the Wuxi production and service site Rolled out global development programs in leadership and corporate culture Continued working in line with its sust
Slide 13: Business outlook
BUSINESS OUTLOOK 5% According to Detection Technology’s view, the medical and industrial markets will grow in line with the pre-pandemic estimates by the experts, on average about 5% per year. The market disturbance caused by the pandemic is passing in the security market, as demand has taken an upw
Slide 14: Financial targets
FINANCIAL TARGETS MEDIUM TERM Annual MEDIUM TERM Operating ANNUAL Dividend or sales growth margin returned capital >10% ≥15% 30-60% 14 27.10.2021 Detection Technology | Business review January–September 2021
Slide 15: Foreknow. Foresave.
FOREKNOW.FORESAVE. ® www.deetee.com